Physicians’ Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE PlatformFabio Efficace, Marco Vignetti, Paolo de Fabritiis et al.|Frontiers in Oncology|2022Cited by 12
Incidence of Clinically Significant (≤10 g/dL) Late Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with ImatinibLaura Cesini, Roberto Latagliata, Ida Carmosino et al.|Oncology Research and Treatment|2019Cited by 9
Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse?Roberto Latagliata, Robin Foà, Massimo Breccia et al.|European Journal Of Haematology|2018Cited by 6
Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical–Biological Entity?Alessia Campagna, Roberto Latagliata, Daniela De Benedittis et al.|Journal of Clinical Medicine|2022Cited by 4
Balanced and unbalanced chromosomal translocations in myelodysplastic syndromes: clinical and prognostic significanceSara Mohamed, Marco Mancini, Roberto Latagliata et al.|Leukemia & lymphoma/Leukemia and lymphoma|2020Cited by 2